429 related articles for article (PubMed ID: 1348883)
1. Monoclonal antibodies against human T cell adhesion molecules--modulation of immune function in nonhuman primates.
Berlin PJ; Bacher JD; Sharrow SO; Gonzalez C; Gress RE
Transplantation; 1992 Apr; 53(4):840-9. PubMed ID: 1348883
[TBL] [Abstract][Full Text] [Related]
2. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
Ferrini S; Sforzini S; Cambiaggi A; Poggi A; Meazza R; Canevari S; Colnaghi MI; Moretta L
Int J Cancer; 1994 Mar; 56(6):846-52. PubMed ID: 7907079
[TBL] [Abstract][Full Text] [Related]
3. Evidence for cell surface association of CD2 and LFA-1 (CD11a/CD18) on T lymphocytes.
Altin JG; Pagler EB; Parish CR
Eur J Immunol; 1994 Feb; 24(2):450-7. PubMed ID: 7905418
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
5. Signaling from LFA-1 contributes signal transduction through CD2 alternative pathway in T cell activation.
Yamada A; Kaneyuki T; Torimoto Y; Daley JF; Prado CM; Yokoyama MM
Cell Immunol; 1992 Jun; 142(1):145-58. PubMed ID: 1375131
[TBL] [Abstract][Full Text] [Related]
6. Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes.
Scheeren RA; Koopman G; Van der Baan S; Meijer CJ; Pals ST
Eur J Immunol; 1991 May; 21(5):1101-5. PubMed ID: 1709862
[TBL] [Abstract][Full Text] [Related]
7. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
8. Syn-capping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells.
Rosenman SJ; Ganji AA; Tedder TF; Gallatin WM
J Leukoc Biol; 1993 Jan; 53(1):1-10. PubMed ID: 7678845
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
[TBL] [Abstract][Full Text] [Related]
10. The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways.
Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; de Waal RM
Transpl Immunol; 1993; 1(3):183-91. PubMed ID: 7521739
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD2 antibodies induce T cell unresponsiveness in vivo.
Gückel B; Berek C; Lutz M; Altevogt P; Schirrmacher V; Kyewski BA
J Exp Med; 1991 Nov; 174(5):957-67. PubMed ID: 1682413
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
13. Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibody.
Dehoux JP; Talpe S; Dewolf N; Otsuka M; Oike F; Jamar F; de la Parra B; Latinne D; Bazin H; Gianello P
Transplantation; 2000 Jun; 69(12):2622-33. PubMed ID: 10910286
[TBL] [Abstract][Full Text] [Related]
14. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
[TBL] [Abstract][Full Text] [Related]
16. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against LFA-1 or its ligand ICAM-1 accelerate CD2 (T11.1 + T11.2)-mediated T cell proliferation.
Cerdan C; Lipcey C; Lopez M; Nunes J; Pierres A; Mawas C; Olive D
Cell Immunol; 1989 Oct; 123(2):344-53. PubMed ID: 2571421
[TBL] [Abstract][Full Text] [Related]
18. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins.
Bierer BE; Golan DE; Brown CS; Herrmann SH; Burakoff SJ
Eur J Immunol; 1989 Apr; 19(4):661-5. PubMed ID: 2471647
[TBL] [Abstract][Full Text] [Related]
20. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
